Recommendation | Median | Mean absolute deviation from the median (MADM) | |
---|---|---|---|
25 | MDT meetings should be a forum for recruiting patients to clinical trials | 8 | 1.19 |
26 | All MDTs should have a designated (rather than a rotating) Chair for MDT meetings | 7 | 1.75 |
27 | All MDTs should have a dedicated MDT coordinator/administrator | 9 | 1.31 |
28 | MDT Chairs should attend at least one other MDT meeting to identify approaches to improve their chairing skills | 8 | 1.56 |
29 | A patient list should be available for all team members to view in advance of an MDT meeting | 8.5 | 1.31 |
30 | Presentations should be explicitly framed in the light of a specific query or issue to be discussed | 8 | 1.13 |
31 | All MDTs should be audited through external peer-review | 8.5 | 1.13 |
32 | There should be time within MDT meetings to discuss current and emerging research and evidence only in relation to the case discussed | 7.5 | 1.25 |
33 | Relevant psychosocial issues for patients presented to each type of MDT should be identified and agreed by the MDT | 7.5 | 1.44 |
34 | The MDT member who presents the case should routinely consider psychosocial factors and ensure that relevant information is available at the meeting | 8 | 1.19 |
35 | Teams should be explicit about the research evidence that they are drawing on when making a decision in the MDT meeting | 7 | 1.25 |
36 | Patients should be given feedback on which professional groups were present when they were discussed at the MDT meeting | 7.5 | 1.69 |
37 | Patients should be given feedback every time they are discussed at an MDT meeting | 8 | 1.25 |
38 | Patients should be given written feedback about the outcome of the MDT meeting | 7 | 1.63 |